Year-End Report — SQUIRE PATTON BOGGS for PAIN THERAPEUTICS INC (2007)

Firm

SQUIRE PATTON BOGGS

Client

PAIN THERAPEUTICS INC

Income

$80,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations P.L. 110-85/HR 3580, Food and Drug Administration Act of 2007 (section on post-market drug safety)

Lobbyist	Covered position, as disclosed
BRET KOPLOW	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3580 (110th)

Alcohol and Drug Abuse ALC

Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations P.L. 110-85/HR 3580, Food and Drug Administration Act of 2007 (section on post-market drug safety)

Lobbyist	Covered position, as disclosed
BRET KOPLOW	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3580 (110th)

Health Issues HCR

Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations P.L. 110-85/HR 3580, Food and Drug Administration Act of 2007 (section on post-market drug safety)

Lobbyist	Covered position, as disclosed
BRET KOPLOW	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3580 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.